| Document |
Document Title |
|
JP5592588B2 |
|
|
JP5590168B2 |
An oligoaniline compound represented by the formula (1) can provide a charge transporting thin film which shows a suppressed coloration in the visible range. Use of this thin film makes it possible to ensure a color reproducibility of a ...
|
|
JP5587310B2 |
The invention relates to new processes to prepare low odor dialkyl sulfides, the low odor dialkyl sulfides obtainable by these processes and to methods of using these low odor dialkyl sulfides. Moreover, the invention relates to a proces...
|
|
JP2014522853A |
A process for the preparation of a compound of formula (I): which is useful as an intermediate in the preparation of pharmaceutically active compounds.
|
|
JP5584632B2 |
An aniline derivative of formula: useful in synthesis of insecticides.
|
|
JP5573079B2 |
|
|
JP5572910B2 |
|
|
JP2014144947A |
To provide a compound that can inhibit histone deacetylase (HDAC) and is suitable as a therapeutic agent for diseases associated with cell proliferation such as malignant tumors.This invention provides a novel stilbene-like compound such...
|
|
JP5567477B2 |
Disclosed are a process suited to large scale synthesis with high yield for producing oseltamivir phosphate, in which a preparation of oseltamivir phosphate which is highly safe as a pharmaceutical product can be produced, and an interme...
|
|
JP5564487B2 |
A process for the preparation of a compound of formula (Ia): which are useful as intermediates in the preparation of i.a. pharmaceutically active compounds.
|
|
JPWO2012127996A1 |
The present invention is obtained as a by-product when a 2- (alkylthio) benzonitrile compound and a halogenating agent are reacted in the presence of water to produce a 1,2-benzisothiazole-3-one compound. Alkyl halide is reacted with a s...
|
|
JP2014517813A |
Derivatives of sulindac that lack cyclooxygenase inhibitory activity are provided along with pharmaceutical compositions containing them and use for treatment or prevention of cancer. The derivatives of sulindac are also suitable for tre...
|
|
JP5557216B2 |
|
|
JP5555175B2 |
The invention provides compounds of formula (I) wherein R1, R3, L1, L2, G1, G2, A and m are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together wit...
|
|
JP5554873B2 |
An ether is provided which may be used in the production of a glycoside, and method of producing the ether. The ether is represented by the following chemical formula (106): in said chemical formula (106), R 4 is a hydrocarbon group, a s...
|
|
JP2014517094A |
Silicic acid containing rubber mixture comprises at least one rubber, a sulfur containing alkoxysilane, a crosslinking agent, a filler, optionally further rubber auxiliary products, and a silicon-free polysulfide additive (I) (0.1-15 par...
|
|
JP2014516919A |
Compounds of the formula (I) or salts thereof, in which R1 is H or a hydrolyzable radical, (R2)n is n substituents R2, where R2 independently of the others is Hal, CN, NO2, (C1-C8)-alkyl, (C1-C8)-alkoxy, (C1-C8)-alkylthio, (C1-C8)-alkyls...
|
|
JP5550340B2 |
A method is described to prepare a Mo containing supported catalyst comprising TeO2 as active promoter and a process for preparing methanethiol in the presence of said catalyst.
|
|
JP5550568B2 |
|
|
JP5546947B2 |
An object of the present invention is to provide a method for producing sulfur-containing carboxylic acid esters that are useful for aromatizing and flavoring purpose and can cater to the needs for diversified aromatized and/or flavored ...
|
|
JP2014515734A |
Triazene-substituted diphenyl derivatives are suitable as chemotherapeutic agents for treating carcinomas in humans and animals.
|
|
JP5538542B2 |
The present invention relates to the use of a compound of formula I wherein R1, R2, R3, R4, X and n are as defined herein or to a pharmaceutically acceptable acid addition salt, to a racemic mixture, or to its corresponding enantiomers a...
|
|
JP5528663B2 |
|
|
JP5524736B2 |
A method for producing methionine includes a hydrolyzing step of hydrolyzing 5-(β-methylmercaptoethyl)hydantoin, and a crystallizing step of crystallizing with carbon dioxide introduced into a reaction solution after hydrolysis, to obta...
|
|
JP5524629B2 |
Cyclohexanedione compounds, and derivatives thereof, which are substituted in 5-position, are suitable for use as herbicides. The cyclohexanedione compounds and derivatives of the invention are compounds of formula (I) wherein the substi...
|
|
JP5523008B2 |
An urethane acrylate compound, or its corresponding salt, solvate or a solvate of a salt, is new. An urethane acrylate compound of formula (I), or its corresponding salt, solvate or a solvate of a salt, is new. R 1-R 5 : H, halo, 1-6C al...
|
|
JP5526120B2 |
A process for the preparation of a compound of formula (I): which are useful as intermediates in the preparation of i.a. pharmaceutically active compounds.
|
|
JP2014108956A |
To provide a method of manufacturing methionine in a short time by proceeding with hydrolysis from a 5-(2-methyl mercaptoethyl)hydantoin solution containing an ammonia component quickly.In a method of manufacturing methionine by hydrolys...
|
|
JP5518280B2 |
A pharmaceutical composition comprising a compound of formula (1) in polymorphic crystalline Form A: together with a pharmaceutically acceptable carrier or excipient, wherein the compound of formula (1) is present in polymorphic Form A (...
|
|
JP5511187B2 |
A manganese dioxide catalyst for hydrolysing organic nitrites which bear readily oxidizable groups such as thiol or thioether groups to the corresponding carboxamides, and to a process for preparing the catalyst and to its use for hydrol...
|
|
JP5508738B2 |
Producing ketone compounds (I), comprises reacting alpha-oxocarboxylate compounds (II) with aryl bromide compounds (III) in the presence of two transition metals or compounds as catalyst. Producing ketone compounds of formula (R-C(=O)-R1...
|
|
JP5502727B2 |
Provided is a process for continuously preparing methyl mercaptan by reacting a reactant mixture comprising solid, liquid and/or gaseous carbon- and/or hydrogen-containing compounds with air or oxygen, and/or water and sulfur.
|
|
JP5497659B2 |
The present invention provides sulfur containing fluoroalkyl amines represented by the formula Rf-Q-S(O) x -C(H) i (CH 3 ) j -(CH 2 ) z+(i-1) -NHR and isocyanate/isothiocyanate derivatives thereof represented by the formula Rf-Q-S(O) x -...
|
|
JP5497773B2 |
The present invention relates to a hydrogenation catalyst, particularly useful for the hydrogenation of carbon disulphide (CS2) to form methyl mercaptan (CH3SH), and to a preparation method thereof. The present invention also relates to ...
|
|
JP5498798B2 |
Disclosed is a simple method for efficiently producing a 3-mercaptoaniline compound which is known as an intermediate for a 3-(1H-1,2,4-triazol-1-yl)phenylsulfide derivative that is useful as a pesticide and the like. Also disclosed is a...
|
|
JPWO2012077456A1 |
The present invention provides a method for synthesizing ethers, esters and thioethers having various functional groups in a high yield and easily. Specifically, the present invention provides a method for producing an ether, an ester or...
|
|
JP5493628B2 |
A process for producing an α-hydroxyketone compound, which comprises subjecting an aldehyde compound to a coupling reaction in the presence of an alkoxyimidazolidine compound represented by the formula (1) wherein R1? and R2? independen...
|
|
JP5492404B2 |
Provided herein are sulfurized metal alkyl phenate compositions having a low alkyl phenol content. The sulfurized metal alkyl phenate compositions can be prepared by reacting a phenol compound of Formula (I) disclosed herein with an alde...
|
|
JP2014080385A |
To provide a compound having an excellent controlling activity on a pest.There is provided an oxime ether compound represented by the formula (1) [where, X represents a trifluoromethyl group or a pentafluorothio group; Y and Z are the sa...
|
|
JP5484065B2 |
There are described compounds of general formula (I) and isomeric forms thereof wherein n is 0, 1, 2 or 3, saturated or unsaturated; most preferably at least one of R1 to R5 represents halogen; at least one of R1, R2, R3, R4 and R5 is se...
|
|
JP5482233B2 |
|
|
JP2014510618A |
The present invention proposes a combination of bis-(gamma-L-glutamyl)-L-cysteinyl-glycine or a salt thereof, inosine and coordination compounds formed by palladium, copper and (gamma-L-glutamyl)-L-cysteinyl-glycine; a pharmaceutical com...
|
|
JP5481850B2 |
To provide a heteroacene derivative which has a long molecular major axis and thereby has high performance, has superior oxidation resistance and further can form a semiconductor active phase through an application method; an oxidation-r...
|
|
JP5479697B2 |
|
|
JP5463839B2 |
The present invention provides a method of using a suitable material for an apparatus used in solid-liquid separation of a residue containing an inorganic salt, left to remain in an organic phase containing 2-hydroxy-4-methylthiobutanoic...
|
|
JP5467770B2 |
The present invention is directed to a novel lysine salts, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by PPAR delta. The present invention is further directed to a nov...
|
|
JP5457555B2 |
The present invention relates to a method for preparing a tricyclic derivative, and more particulary, to a method for preparing a tricyclic derivative inetermediate with high yield and purity, the method including: introducing a hydroxy ...
|
|
JP5455368B2 |
The present invention relates to a process for preparing a porous metal-organic framework by reacting at least one metal compound in which the metal is Be, Mg, Ca, Sr, Ba, Al, Ga or In with at least one at least bidentate organic compoun...
|
|
JP5455636B2 |
The present invention relates to a compound as a peroxisome proliferator activated receptor (PPAR) activator and a hydrate, a solvate, a stereoisomer and a pharmaceutically acceptable salt thereof, and a pharmaceutical composition, a cos...
|
|
JP5438287B2 |
|
